Prognosis of prolonged disorders of consciousness outcome based on the determination of certain hormones and natriuretic peptide

Introduction: Changes in hormonal status in patients with prolonged disorders of consciousness (PDC) remain poorly understood. There are no studies devoted to the investigation of prognostic value of hormonal changes to predict the outcome which is primarily due to a relatively small number of patients, different variants of structural brain disorders in vegetative state (VS) patients, concomitant somatic pathology including typical complications.
The objective: to study the correlation between outcomes in VS patients with hormonal status and the level of natriuretic peptide. Subjects and methods. 275 patients in VS were examined for the time period from 2007 to 2017. 152 patients had sequela of traumatic brain injury (TBI) and 123 patients suffered from hypoxic brain damage. All patients matched the international criteria of VS diagnosis. In all patients, blood samples were collected during the first week after admission to ICU to test hormones and natriuretic peptide levels. ACTH, cortisol, TSH, free T₃ and T₄ , STH, prolactin and natriuretic peptide were tested in the period from 2 to 4 months of staying in VS. In men, the level of total testosterone, LH and FSH was additionally tested. The obtained data were compared with VS outcome.
Results. The tested hormones were stably insufficient only in few VS patients. None of the tested hormones of the hypothalamic-pituitary-adrenal axis made a reliable criterion for predicting VS outcome. The tendency of disrupted rhythm of cortisol secretion was found to be most frequent and consistent, with higher rates in the evening hours. The average value of STH was higher in men with sequela of traumatic brain injury who had recovered consciousness versus those who remained in VS. A significant decrease in testosterone levels, regardless of age, was found in the patients with TBI sequela. Mean levels of LH were higher in patients with TBI sequela and hypoxia who remained unconscious versus patients who later restored consciousness. The average level of FSH was higher in patients who had recovered consciousness compared to those who remained in chronic VS. The increased level of natriuretic peptide was observed both in patients who remained in chronic VS and in those who restored consciousness.
Conclusions. When investigating levels of certain hormones, no specific endocrine background characterizing this category of patients was found. Abnormal rhythms of some hormones secretion, in particular cortisol, can be considered typical of VS patients especially patients with TBI sequela.

1. Kudlay D.A. [Immunometabolicheskie aspekty patogeneza politravmy. Avtoref. diss. dokt. med. nauk]. Immunometabolic approaches to multiple trauma pathogenesis. Synopsis of Doct. Diss. Novosibirskiy Gosudarstvenny Meditsinskiy Universitet Federalnogo Agentstva Po Zdravookhraneniyu i Sotsialnomu Razvitiyu RF Publ., Novosibirsk, 2007.

2. Tsentsiper L.M., Kondratiev А.N., Dryagina N.V. N-terminal probrain natriuretic peptide is a biomarker of acute cerebral injury. Anesteziologiya i Reanimatologiya, 2015, vol. 60, no. 4, pp. 24-27. (In Russ.)

3. Azcoitia I., Sierra A., Veiga S. et al. Aromatase expression by reactive astroglia is neuroprotective. Ann. N Y Acad. Sci., 2003, vol. 1007, pp. 298‒305.

4. Bohara M., Kambe Y., Nagayama T. et al. C-type natriuretic peptide modulates permeability of the blood-brain barrier. J. Cereb. Blood. Flow Metab., 2014, vol. 34, no. 4, pp. 589-596.

5. Cao L. H., Yang X. L. Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol., 2008, vol. 84, no. 3, pp. 234‒248.

6. de Bold A.J., Borenstein H.B., Veress A.T. et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci., 1981, vol. 28, no. 1, pp. 89‒94.

7. Decker J.M., Wojtowicz A.M., Bartsch J.C. et al. C-type natriuretic peptide modulates bidirectional plasticity in hippocampal area CA1 in vitro. Neuroscience, 2010, vol. 169, no. 1, pp. 8‒22.

8. Decker J.M., Wojtowicz A.M., Ul Haq R. et al. C-type natriuretic peptide decreases hippocampal network oscillations in adult rats in vitro. Neuroscience, 2009, vol. 164, no. 4, pp. 1764-1775.

9. Garcia-Segura L.M., Veiga S., Sierra A. et al. Aromatase: a neuroprotective enzyme. Prog Neurobiol., 2003, vol. 71, no. 1, pp. 31‒41.

10. Giacino J.T., Katz D.I., Schiff N.D. et al. Practice Guideline Update Recommendations Summary: Disorders of Consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Archives of Physical Medicine and Rehabilitation, 2018, vol. 99, no. 9, pp. 1699‒1709.

11. Ito T., Saitoh D., Takasu A. et al. Serum cortisol as a predictive marker of the outcome in patients resuscitated after cardiopulmonary arrest. Resuscitation, 2004, vol. 62, no. 1, pp. 55‒60.

12. James M.L., Wang H., Venkatraman T. et al. Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J. Neurotrauma, 2010, vol. 27, no. 1, pp. 217‒228.

13. Mahinrad S., Bulk M., van der Velpen I. et al. Natriuretic peptides in post-mortem brain tissue and cerebrospinal fluid of non-demented humans and alzheimer’s disease patients. Front Neurosci., 2018, vol. 26, no. 12, pp. 864.

14. Mahinrad S., de Craen A.J., Yasar S. et al. Natriuretic peptides in the central nervous system: novel targets for cognitive impairment. Neurosci Biobehav Rev., 2016, vol. 68, pp. 148‒156.

15. Moriyama N., Taniguchi M., Miyano K. et al. ANP inhibits LPS-induced stimulation of rat microglial cells by suppressing NF-kappaB and AP-1 activations. Biochem Biophys Res Commun., 2006, vol. 350, pp. 322-328.

16. Munno I., Damiani S., Scardapane R. et al. Evaluation of hypothalamic-pitu itary-adrenocortical hormones and inflammatory cytokines in patients with persistent vegetative state. Immunopharmacol Immunotoxicol., 1998, vol. 20, no. 4, pp. 519‒522.

17. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev., 2006, vol. 27, pp. 47-72.

18. Prado J., Baltrons M.A., Pifarré P. et al. Glial cells as sources and targets of natriuretic peptides. Neurochem Int., 2010, vol. 57, no. 4, pp. 367-374.

19. Roberts I., Yates D., Sandercock P. et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo-controlled trial. Lancet, 2004, vol. 364, pp. 1321-1328.

20. Suzuki T., Yamazaki T., Yazak Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovasc. Res., 2001, vol. 51, no. 3, pp. 489-494.

21. Telegdy G., Adamik A., Glover V. The action of isatin (2,3-dioxoindole) an endogenous indole on brain natriuretic and C-type natriuretic peptide-induced facilitation of memory consolidation in passive-avoidance learning in rats. Brain Res. Bull., 2000, vol. 53, no. 3, pp. 367‒370.

22. van der Velpen I.F., Feleus S., Bertens A.S. et al. Hemodynamic and serum cardiac markers and risk of cognitive impairment and dementia. Alzheimers Dement., 2017, vol. 13, no. 4, pp. 441‒453.

23. Wagner A.K., McCullough E.H., Niyonkuru C. et al. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J. Neurotrauma, 2011, vol. 28, pp. 871-888.

24. Yang S.H., Liu R., Wen Y. et al. Neuroendocrine mechanism for tolerance to cerebral ischemia-reperfusion injury in male rats. J. Neurobiol., 2005, vol. 15, no. 62, pp. 341‒351.

25. Yang S.H., Perez E., Cutright J. et al. Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J. Appl. Physiol., 2002, vol. 92, no. 1, pp. 195‒201.

26. Yoshimoto H., Uozumi T. Anterior pituitary function in the vegetative state. Neurol Med Chir (Tokyo), 1989, vol. 29, no. 6, pp. 490‒495.